Advertisement

Topics

Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals

11:44 EDT 13 May 2019 | Investing News Network

Onconova Therapeutics (NASDAQ:ONTX) has announced it has entered into a license agreement with HanX Biopharmaceuticals for the Greater China territory. As quoted in the press release: Under the terms of the agreement, Onconova has granted to HanX (i) an exclusive license to develop and commercialize rigosertib in Greater China and (ii) a non-exclusive license to … Continued

The post Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals appeared first on Investing News Network.

Original Article: Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals

NEXT ARTICLE

More From BioPortfolio on "Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...